Low-dose tamoxifen for combination hormone replacement therapy users

被引：3
|
作者：
Fabian, Carol J. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 27期
关键词：
ITALIAN RANDOMIZED-TRIAL; ESTROGEN-PLUS-PROGESTIN; BREAST-CANCER; POSTMENOPAUSAL WOMEN; DENSITY; RISK; HYSTERECTOMY; PREVENTION;
D O I：
10.1200/JCO.2007.11.9743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4162 / 4164
页数：3
相关论文
共 50 条
  • [1] Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users
    Rondanina, Gabriella
    Puntoni, Matteo
    Severi, Gianluca
    Varricchio, Clara
    Zunino, Anna
    Feroce, Irene
    Bonanni, Bernardo
    Decensi, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1537 - 1543
  • [2] A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study
    DeCensi, A.
    Bonanni, B.
    Maisonneuve, P.
    Serrano, D.
    Omodei, U.
    Varricchio, C.
    Cazzaniga, M.
    Lazzeroni, M.
    Rotmensz, N.
    Santillo, B.
    Sideri, M.
    Cassano, E.
    Belloni, C.
    Muraca, M.
    Segnan, N.
    Masullo, P.
    Costa, A.
    Monti, N.
    Vella, A.
    Bisanti, L.
    D'Aiuto, G.
    Veronesi, U.
    ANNALS OF ONCOLOGY, 2013, 24 (11) : 2753 - 2760
  • [3] Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users
    Decensi, Andrea
    Gandini, Sara
    Serrano, Davide
    Cazzaniga, Massimiliano
    Pizzamiglio, Maria
    Maffini, Fausto
    Pelosi, Giuseppe
    Daldoss, Cristina
    Omodei, Umberto
    Johansson, Harriet
    Macis, Debora
    Lazzeroni, Matteo
    Penotti, Mauro
    Sironi, Laura
    Moroni, Simona
    Bianco, Vanda
    Rondanina, Gabriella
    Gjerde, Jennifer
    Guerrieri-Gonzaga, Aliana
    Bonanni, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4201 - 4209
  • [4] Endometrial Profile of Tamoxifen and Low-Dose Estradiol Combination Therapy
    Wood, Charles E.
    Kaplan, Jay R.
    Fontenot, M. Babette
    Williams, J. Koudy
    Cline, J. Mark
    CLINICAL CANCER RESEARCH, 2010, 16 (03) : 946 - 956
  • [5] Low-dose hormone replacement therapy: effects on bone
    Gambacciani, M
    Monteleone, P
    Genazzani, AR
    CLIMACTERIC, 2002, 5 (02) : 135 - 139
  • [6] Low-dose hormone replacement-therapy for hot flashes
    Mikhail, N
    MAYO CLINIC PROCEEDINGS, 2003, 78 (03) : 379 - 379
  • [7] Low-dose hormone therapy in the perimenopause
    De Franciscis, P.
    Cobellis, L.
    Fornaro, F.
    Sepe, E.
    Torella, M.
    Colacurci, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 98 (02) : 138 - 142
  • [8] Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer
    Comerci, JT
    Fields, AL
    Runowicz, CD
    Goldberg, GL
    GYNECOLOGIC ONCOLOGY, 1997, 64 (03) : 425 - 430
  • [9] CONTINUOUS LOW-DOSE ESTROGEN AND PROGESTOGEN HORMONE REPLACEMENT THERAPY - A RANDOMIZED TRIAL
    MACLENNAN, AH
    MACLENNAN, A
    WENZEL, S
    CHAMBERS, HM
    ECKERT, K
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (02) : 102 - 106
  • [10] Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women
    Gambacciani, Marco
    Cappagli, Barbara
    Ciaponi, Massimo
    Pepe, Antonia
    Vacca, Francesca
    Genazzani, Andrea Riccardo
    MATURITAS, 2008, 59 (01) : 2 - 6
12345